St. Louis vaccine startup expands C-suite and gets new name
The startup's new CEO says he wants to help the company pursue a clinical trial for one of its vaccine targets. The leadership additions come as the startup has rebranded by switch…
The startup's new CEO says he wants to help the company pursue a clinical trial for one of its vaccine targets. The leadership additions come as the startup has rebranded by switch…